- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
If $100G Cancer Drugs Worry You, Join Us! 'Cancer Drug Racket' Article, 'Morning Joe' Segment Draw Attention to Debate Over Balancing Care, Cost in Oncology
With the US Food and Drug Administration busier than ever with breakthrough and priority review designations, and the rise of genetic-based treatments offering new hope for patients and families, the pressure is on oncologists to push the limits in care. But if it costs $200,000 to extend life just a few weeks, does that make sense? Are doctors having that conversation? When they do, are patients hearing it? These are the very issues that will be on the table in Baltimore Nov. 14-15 when The American Journal of Managed Care convenes experts from the front line.
FOR IMMEDIATE RELEASE October 22, 2013
If $100G Cancer Drugs Worry You, Join Us!
‘Cancer Drug Racket’ Article, ‘Morning Joe’ Segment Draw Attention
to Debate Over Balancing Care, Cost in Oncology
Baltimore Meeting Nov. 14-15 to Bring Experts Together on How to Make Tough Calls
PLAINSBORO, N.J. — From the article in New York magazine that called some current therapies a “cancer drug racket,” to Dr. Zeke Emanuel’s appearance this week on MSNBC’s “Morning Joe,’ there is growing awareness of the tough decisions that doctors and health plan executives must make as both the breakthroughs and costs escalate in the world of cancer care.
With the US Food and Drug Administration busier than ever with “breakthrough” and “priority review” designations, and the rise of genetic-based treatments offering new hope for patients and families, the pressure is on oncologists to push the limits in care. But, as Emanuel explained on MSNBC, if it costs $200,000 to extend life just a few weeks, does that make sense? And, he explained further, are doctors having that conversation? When they do, are patients hearing it?
These are the very issues that will be on the table in Baltimore Nov. 14-15 when The American Journal of Managed Care convenes experts from the front lines — clinical and academic leaders, developers of life-saving therapies, and those who are transforming the way healthcare does business. For more information about the conference and a proposed agenda, please visit the web site at: http://www.ajmc.com/meetings/oncologycare13.
“Patient-Centered Oncology Care: Real World Perspectives” will take place November 14-15 at the Royal Sonesta Harbor Court, Baltimore. This two-day conference, which features an evening networking reception, will bring together key leaders in managed care and beyond. All will share how the goals of better care, savings and fair compensation can be achieved, even in the world of oncology.
Attend this conference if you want to know:
- How cancer care delivery will change under accountable care organizations (ACOs)
- How consumer voices will change the management of cancer care
- How to understand the balance between cost and quality in end-of-life care
- How pharmaceutical companies and insurers can work together
Credentialed media who wish to register for the conference must contact Nicole Beagin or Mary Caffrey at (609) 716-7777. A limited number of hotel rooms have been reserved, but members of the media must contact Nicole Beagin to hold a room at the conference rate.
Highlights on major speakers at the conference are attached.
CONTACT:
Nicole Beagin (609) 716-7777 x. 131
Mary Caffrey (609) 716-7777 x. 144
Follow us on @AJMC_Journal and @EBOncology
Health Care Utilization and Cost of Diagnostic Testing for Respiratory Infections
September 17th 2025Syndromic reverse transcriptase–polymerase chain reaction tests for respiratory infections were associated with lower health care resource utilization and costs, implicating potential for improved value in patient care.
Read More
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
